Sleep Science: Jan 2, 2026

This comprehensive review examines how pediatric obesity impacts sleep health, particularly through obstructive sleep apnea (OSA) and obesity hypoventilation syndrome (OHS). The paper emphasizes that multidisciplinary care, including nutritional counseling, physical activity, psychological support, and emerging GLP-1 medications, is essential for managing these interconnected conditions. The review highlights how obesity creates a vicious cycle: excess weight leads to sleep-disordered breathing, which in turn worsens metabolic dysfunction and promotes further weight gain. Although GLP-1 receptor agonists show promise for weight reduction in adolescents, their impact on sleep disorders remains understudied.

This groundbreaking study of 371 children aged 4-9 years found that 22.7% had undiagnosed OSA, much higher than previously reported. The research used both questionnaires and home sleep tests to reveal that each 1-unit increase in BMI z-score was associated with 1.35 times higher risk of moderate/severe OSA. Childhood overweight increased OSA risk by 2.71 times, while obesity increased it by 2.80 times. Even weight gain since 18 months of age was linked to higher OSA risk. This suggests OSA screening should be routine in overweight children.

Researchers tested a mobile health app designed to help parents manage their school-aged children's insomnia. The study involved 28 parents and showed small but positive effects: improved sleep habits, reduced insomnia severity, and better daytime functioning in children. While the app showed promise, daily usage was lower than expected, suggesting the need for further refinement. This represents an important step toward accessible, evidence-based digital sleep interventions for families.

This study explored the biological mechanisms behind adenoid hypertrophy (enlarged adenoid tissue), a leading cause of pediatric OSA. Using RNA sequencing and tissue analysis, researchers identified ferroptosis, a type of iron-dependent cell death, as playing a key role. Interestingly, children with more severe adenoid hypertrophy showed reduced ferroptosis, suggesting cells develop resistance to this death pathway, allowing excessive tissue growth. The study identified 7 hub genes that could serve as biomarkers or therapeutic targets. In lab experiments, inducing ferroptosis suppressed adenoid cell growth.